New perspectives on rheumatoid arthritis |
| |
| Affiliation: | 1. Department of Pathology, University of Michigan Health System, Ann Arbor, MI 48109;2. Department of Dermatology, University of Michigan Health System, Ann Arbor, MI 48109;3. Michigan Center for Translational Pathology, University of Michigan Health System, Ann Arbor, MI 48109;4. Department of Urology, University of Michigan Health System, Ann Arbor, MI 48109;5. Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI 48109;1. Department of Agricultural Food and Nutritional Science, 4-126 Li Ka Shing Centre for Health Research Innovation, University of Alberta, Edmonton, AB, T6G 2P5, Canada;2. Department of Surgical Oncology, University of Calgary, Canada;3. Department of Oncology, Cross Cancer Institute, University of Alberta, Canada |
| |
| Abstract: | Rheumatoid arthritis (RA) remains one of the most common, puzzling and poorly treated diseases of humans. However, a surge of interest in the biology of chronic inflammation and in the design of more-potent and specific inhibitors of pro-inflammatory pathways heralds an optimistic era for the treatment of RA. A recent symposium1 provided a multidisciplinary perspective on the current status of such studies. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
